Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

What is Cancer?

Cancer is refers to a group of more than a hundred diseases that can originate in many different parts of the body.

What Role do Biobanks Play in Cancer Research?

Is Cancer a Metabolic Disorder?

The Effects of Cancer on Family Life

Cancer Prevention: Lowering your Risk

Cutaneous Manifestations of Internal Malignancy

What is Cancer of Unknown Primary?

Caring for a Loved One with Cancer

British Pioneers in Cancer Biology

Assay for Monitoring and Treating Malignant Brain Tumors

Extracellular Vesicles as Floating Cancer Biomarkers

Microfluidic cancer treatment screen combined with flow cytometry

Overview of Cell Viability and Cytotoxicity

Using Biomarkers to Detect Cancer

Why are Cancer Cell Lines Useful?

Hypoxia Markers and Their Importance

What is the Tumor Microenvironment?

Metastatic Migration in Cancer may be Influenced by Metabolism

The Cancer Cell Surface Proteome as a Therapeutic Target

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

TARDIS: The Improved Method of Detecting Breast Cancer

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Investigating the Molecular Mechanisms of Cancer

Acidosis and Tumor Progression

What is Merkel Cell Carcinoma?

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

The Biochemistry of Breast Cancer Screening

Hot vs Cold: the differences between tumor types

Transforming Cancer Care through Genomic Testing

Exploiting Enzymes in Cancer Diagnosis and Therapy

Latest Cancer News and Research

Mainz Biomed to unveil breakthrough early cancer detection study results at DDW 2024

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, will present an analysis from its eAArly DETECT study at Digestive Disease Week (DDW) 2024 in Washington D.C. from May 18th to May 21st. DDW is recognized as a premier forum for the latest advancements in gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.

11 May 2024

Scripps Research professor emeritus John Johnson selected as member of the National Academy of Sciences

Scripps Research professor emeritus John Johnson, PhD, has been elected to the National Academy of Sciences—one of the highest honors given to scientists.

11 May 2024

NHS still faces waiting list challenges

Commenting on the publication today of the NHS monthly performance statistics, Tim Gardner, Assistant Director of Policy at the Health Foundation, said.

11 May 2024

Expanding treatment horizons for hypermutated urothelial carcinomas beyond immunotherapy

A new editorial paper was published in Oncoscience (Volume 11) on April 25, 2024, entitled, "Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy."

10 May 2024

Study spotlights differences based on race and gender in melanoma diagnosis, outcomes

Melanoma, an aggressive form of skin cancer that accounts for 75% of all skin-cancer-related deaths, is often detected later in people with darker skin complexions -; and the consequences can be devastating, a Mayo Clinic study reveals.

10 May 2024

DoD grant awarded for investigating alternative polyadenylation in prostate cancer

A team led by Dr. Eddie Imada, assistant professor of research in pathology and laboratory medicine, has been awarded a three-year, $1.5 million United States Department of Defense grant for research on a cellular process called alternative polyadenylation and its role in prostate cancer.

10 May 2024

Chemotherapy linked to physical decline in older women with high-risk breast cancer

A UCLA-led study suggests women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function.

10 May 2024

Researchers discover a 'training program' driving parietal cell development

Common conditions such as indigestion and heartburn as well as peptic ulcers, autoimmune gastritis and stomach and esophageal cancers have one thing in common – they involve disruptions of the normal activity of parietal cells (PCs) in the stomach, the only cells in the body that produce acid.

10 May 2024

New collaboration to combat river blindness and lymphatic filariasis

Prof. Achim Hoerauf, Director of the Institute of Medical Microbiology, Immunology and Parasitology at the University Hospital Bonn (UKB), and his team have succeeded in collaborating with the Department of Pharmaceutical Technology and Biopharmacy at the University of Bonn and the Helmholtz Center for Infection Research (HZI), to enter into a partnership with the Japanese pharmaceutical company Eisai for the further development of the antibiotic corallopyronin A (CorA) as a treatment for the neglected tropical diseases river blindness and lymphatic filariasis and to raise a large amount of funding.

10 May 2024

FDA-approved TIVDAK®: Targeting tissue factor in cervical cancer

On April 29th, 2024, the U.S. FDA granted full approval for Seagen Inc.'s TIVDAK® (tisotumab vedotin) targeting tissue factor (TF) for the treatment of patients with recurrent or metastatic cervical cancer who have progressed on or after chemotherapy. This marks a significant advancement in the therapeutic landscape for cervical cancer, highlighting the potential of antibody-drug conjugates (ADCs) in oncology.

10 May 2024

Can living in flood-prone areas increase your risk of death?

The long-term effects of flooding on mortality.

10 May 2024

Frequent salt addition at the table increases gastric cancer risk by 41%

Addition of salt to food at the table and risk of developing stomach cancer.

10 May 2024

AML patients at the extremes of older age derive benefit from VEN-HMA regimen

Standard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over 80, according to a study published in Blood Neoplasia. For roughly a quarter of patients, this treatment can durably prolong survival.

9 May 2024

Breakthrough research offers promise for developing new immune therapies for cancer

Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer.

9 May 2024

Breakthrough vaccine strategy guides the immune system to generate HIV neutralizing antibodies

A team led by the Duke Human Vaccine Institute (DHVI) has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against HIV.

9 May 2024

Combination immunotherapy treatment enhances immune response for people with malignant gliomas

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an aggressive type of brain tumor that is fast growing and difficult to treat.

9 May 2024